100 North Mario Capecchi Drive, Salt Lake City, UT, 84113 · (801) 662-1000
Beds
353
FY 2025
Star rating
Not rated
Overall rating
Net patient revenue
$1.47B
FY 2025
Net income
$326.1M
Patient care margin 14.7%
Discharges
18,039
Occupancy 80.7%
Clinicians
30
Medicare clinicians who work here
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $1.47B | $1.25B | 14.7% | $326.1M | 18,039 | -$191 | 0.1% | 9.9% |
Medicare clinicians who list this hospital, by specialty
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | - | - | - | $1,219.56 |
| APC 5073 Level 3 Excision/ Biopsy/ Incision and Drainage | - | - | - | $2,141.49 |
| APC 5163 Level 3 ENT Procedures |
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
| 2024 | $1.22B | $1.13B | 7.1% | $191.8M | 13,471 | -$76 | 0.0% | 12.8% |
| 2023 | $1.02B | $944.5M | 7.2% | $187.6M | 13,460 | -$468 | 0.0% | 13.8% |
| 2022 | $895.5M | $845.3M | 5.6% | $167.2M | 13,840 | -$685 | 0.3% | 8.3% |
| 2021 | $765.9M | $707.3M | 7.7% | $136.1M | 12,515 | $14.6M | 0.2% | 7.4% |
| 2020 | $655.6M | $653.8M | 0.3% | $105.7M | 10,807 | $16.0M | 0.2% | 14.0% |
| - |
| - |
| - |
| $1,105.91 |
| APC 5373 Level 3 Urology and Related Services | - | - | - | $1,516.28 |
| APC 5464 Level 4 Neurostimulator and Related Procedures | - | - | - | $18,464.57 |
Reported payments to this teaching hospital
| Company | Payments | Amount |
|---|---|---|
| Janssen Scientific Affairs, LLC JNJ | 4 | $393K |
| Ethicon Inc. JNJ | 8 | $311K |
| Janssen Research & Development, LLC JNJ | 7 | $205K |
| Fresenius Medical Care Renal Therapies Group, LLC. | 8 | $139K |
| Fresenius USA Marketing, Inc. | 4 | $121K |
| Genentech, Inc. ROG.SW | 24 | $82K |
| Biosense Webster, Inc. JNJ | 3 | $39K |
| Radiometer America, Inc | 2 | $34K |
| Berlin Heart Inc | 3 | $24K |
| Shockwave Medical, Inc JNJ | 1 | $21K |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Primary Children's Hospital is a nonprofit children's hospital in Salt Lake City, UT with 353 beds, part of Intermountain Health.
Primary Children's Hospital in Salt Lake City, UT has 353 beds (fiscal year 2025 cost report); 232 beds are certified for Medicare. It discharged 18,039 inpatients that year, with 80.7% of its beds in use on average.
In fiscal year 2025 (ending 2025-12-31), Primary Children's Hospital reported net patient revenue of $1.47B and operating expenses of $1.25B, a margin on patient care of 14.7%. After other income and expenses its net income was $326.1M (20.6% of revenue), so it made a profit that year.
Primary Children's Hospital is part of Intermountain Health, a health system with 29 hospitals based in Salt Lake City, UT. It is a nonprofit hospital.
Primary Children's Hospital has no overall star rating, usually because it reports too few quality measures (for example small, specialty or federal hospitals).
Yes, Primary Children's Hospital provides emergency services.
30 Medicare clinicians list Primary Children's Hospital as a hospital they work at, most often in Pediatric Medicine, Diagnostic Radiology, Nephrology.
In 2025, companies reported $1.4M in payments to Primary Children's Hospital as a teaching hospital ($32K general and $1.4M for research) from 14 companies.